The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication in vitro and decreases viral titers and disease progression in Syrian hamsters - Shytaj, Iart Luca; Fares, Mohamed; Gallucci, Lara; Lucic, Bojana; Tolba, Mahmoud M.; Zimmermann, Liv; Adler, Julia M.; Xing, Na; Bushe, Judith; Gruber, Achim D.; Ambiel, Ina; Taha Ayoub, Ahmed; et al. (mBio, 2022)
Gesehen am 31.05.2022